While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Bila Solar is manufacturing ultra-lightweight solar modules and newly launched 550 W dual-glass conventional panels in its ...

Behind-the-scenes video captures this milestone for American solar - creating local jobs and reinforcing why federal support ...

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

Bila Solar has started module production in Indiana and T1 Energy is preparing to build a 5 gigawatt, $850M solar cell ...

The initial report of monotherapy with the BCL-2 inhibitor venetoclax showed it had durable clinical activity and favorable ...

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

Bila Solar has begun producing its new line of silicon solar panels at its Indianapolis factory, the company announced. “This ...